Similar Articles
Use of Clozapine in the Treatment-Resistant Schizoprenia
Oğuzhan Kütük
DOI: 10.5606/jebms.2020.75609
Issue: 2020, Volume 1 - Issue 1
2125
1653
Glucagon-Like Peptide-1 and Psychiatric Disorder
Ayşe Şiva Acar, Oytun Erbaş
DOI: 10.5606/jebms.2021.75645
Issue: 2021, Volume 2 - Issue 2
5162
2343
Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review
Dildar Savcı, Sultan Karadeniz, Oytun Erbaş
DOI: 10.5606/jebms.2021.75683
Issue: 2021, Volume 2 - Issue 3
2041
1415
Gluten and Casein: Their Roles in Psychiatric Disorders
Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş
DOI: 10.5606/jebms.2022.1003
Issue: 2022, Volume 3 - Issue 1
16975
2873
Microglial Effects on Psychiatric Disorders
Hadi Sasani, Oytun Erbaş
DOI: 10.5606/jebms.2022.1005
Issue: 2022, Volume 3 - Issue 1
1199
977
Understanding the Role of DISC1 in Psychiatric Disorders
Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş
DOI: 10.5606/jebms.2022.1011
Issue: 2022, Volume 3 - Issue 1
3541
1183
Association of NOS1AP Variants in Schizophrenia
Ayşenur Saygılı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1013
Issue: 2022, Volume 3 - Issue 1
2065
972
N-Methyl D-Aspartic Acid Receptors: An Overview
Dilek Daşdelen, Aylin Kayaaltı, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2022.1018
Issue: 2022, Volume 3 - Issue 2
6485
1120
Schizophrenia Susceptibility Genes
Beyza Nur Akı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1027
Issue: 2022, Volume 3 - Issue
1728
1166
An Overview of Antipsychotics: Mechanisms of Action
Öznur Demirci, İrem Adar, Oytun Erbaş
DOI: 10.5606/jebms.2023.1047
Issue: 2023, Volume 4 - Issue 1
11868
2752
N-Acetyl Cysteine: A Potential Adjunctive Therapy in Psychiatric Disorders
Esma Khoja, Oytun Erbaş
DOI: 10.5606/jebms.2024.1088
Issue: 2024, Volume 5 - Issue 2
6855
1046